Yahoo
LSE - Delayed Quote GBp

Creo Medical Group PLC (CREO.L)

11.38 0.00 (0.00%)
At close: October 30 at 3:16:42 PM GMT
View in AlphaSpace Currency in GBP All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
7,000
6,000
4,000
4,000
27,200
Cost of Revenue
4,100
3,600
2,100
1,700
14,000
Gross Profit
2,900
2,400
1,900
2,300
13,200
Operating Expense
20,500
21,900
30,700
29,200
43,900
Operating Income
-17,600
-19,500
-28,800
-26,900
-30,700
Net Non Operating Interest Income Expense
-100
300
-200
500
-200
Pretax Income
-15,900
-17,500
-29,000
-26,400
-30,900
Tax Provision
0
0
-1,200
-2,700
-4,000
Net Income Common Stockholders
-20,100
5,300
-28,700
-21,700
-26,900
Diluted NI Available to Com Stockholders
-20,100
5,300
-28,700
-21,700
-26,900
Basic EPS
-0.05
0.01
-0.08
-0.07
-0.14
Diluted EPS
-0.05
0.01
-0.08
-0.07
-0.14
Basic Average Shares
415,528.88
412,446.29
369,978.97
313,004.40
187,894.60
Diluted Average Shares
415,528.88
415,340.97
369,978.97
313,004.40
187,894.60
Total Operating Income as Reported
-16,100
-17,800
-28,800
-26,900
-30,700
Total Expenses
24,600
25,500
32,800
30,900
57,900
Net Income from Continuing & Discontinued Operation
-20,100
5,300
-28,700
-21,700
-26,900
Normalized Income
-15,900
-17,500
-27,800
-23,700
-26,900
Interest Income
300
600
200
700
100
Interest Expense
400
300
400
200
300
Net Interest Income
-100
300
-200
500
-200
EBIT
-15,500
-17,200
-28,600
-26,200
-30,600
EBITDA
-14,600
-16,200
-26,100
-22,800
-27,500
Reconciled Cost of Revenue
4,100
3,600
2,100
1,700
14,000
Reconciled Depreciation
900
1,000
2,500
3,400
3,100
Net Income from Continuing Operation Net Minority Interest
-15,900
-17,500
-27,800
-23,700
-26,900
Total Unusual Items Excluding Goodwill
--
--
--
0
0
Total Unusual Items
--
--
--
0
0
Normalized EBITDA
-14,600
-16,200
-26,100
-22,800
-27,500
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 12/9/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: